Short Interest in Small Pharma Inc. (OTCMKTS:DMTTF) Rises By 29.0%

Small Pharma Inc. (OTCMKTS:DMTTFGet Rating) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 50,200 shares, an increase of 29.0% from the May 31st total of 38,900 shares. Based on an average trading volume of 48,900 shares, the short-interest ratio is currently 1.0 days.

Small Pharma stock traded up $0.00 during mid-day trading on Monday, hitting $0.09. The company’s stock had a trading volume of 100 shares, compared to its average volume of 51,224. The firm’s 50 day moving average is $0.12 and its 200 day moving average is $0.17. Small Pharma has a 52-week low of $0.06 and a 52-week high of $0.97.

Small Pharma Company Profile (Get Rating)

Small Pharma Inc, a biotechnology company, develops short-acting psychedelics for the treatment of mental health conditions. The company's lead product candidate is SPL026, a treatment for depressive disorder that is in Phase IIa trial. Its preclinical product candidates include SPL028 and SPL029 tryptamine analogues; and SPL801, an oral formulation of 6 -hydroxynorketamine.

See Also

Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with MarketBeat.com's FREE daily email newsletter.